135 related articles for article (PubMed ID: 36866238)
1. ETNK2 Low-Expression Predicts Poor Prognosis in Renal Cell Carcinoma with Immunosuppressive Tumor Microenvironment.
Chu J; Qian XX; Zhang XM; Jiang T; Li XJ; Sun W
J Oncol; 2023; 2023():1743357. PubMed ID: 36866238
[TBL] [Abstract][Full Text] [Related]
2. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive investigation discovered the novel methyltransferase METTL24 as one presumably prognostic gene for kidney renal clear cell carcinoma potentially modulating tumor immune microenvironment.
Jiang Z; Zhang W; Zeng Z; Tang D; Li C; Cai W; Chen Y; Li Y; Jin Q; Zhang X; Yin L; Liu X; Xu Y; Dai Y
Front Immunol; 2022; 13():926461. PubMed ID: 36311770
[TBL] [Abstract][Full Text] [Related]
4. GRAMD1A Is a Biomarker of Kidney Renal Clear Cell Carcinoma and Is Associated with Immune Infiltration in the Tumour Microenvironment.
Liu Y; Fu S; Zhang Z; Wang S; Cheng X; Li Z; Ding Y; Sun T; Ma M
Dis Markers; 2022; 2022():5939021. PubMed ID: 35860689
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma.
Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D
Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389
[TBL] [Abstract][Full Text] [Related]
6. C1QC is a prognostic biomarker with immune-related value in kidney renal clear cell carcinoma.
Yao W; Liu H; Xu F; Cai Z; Hang L; Lu M; Zhao Y; Yang C; Zong Y
Front Genet; 2023; 14():1109991. PubMed ID: 36992705
[No Abstract] [Full Text] [Related]
7. Diagnostic and prognostic role of basic leucine zipper transcription factor in kidney renal clear cell carcinoma.
Zhang H; Zhang H; Hu Y; Huang B; Chen J; Chen L
Transl Androl Urol; 2022 Feb; 11(2):238-252. PubMed ID: 35280662
[TBL] [Abstract][Full Text] [Related]
8. KCNN4 is a potential prognostic marker and critical factor affecting the immune status of the tumor microenvironment in kidney renal clear cell carcinoma.
Chen S; Wang C; Su X; Dai X; Li S; Mo Z
Transl Androl Urol; 2021 Jun; 10(6):2454-2470. PubMed ID: 34295732
[TBL] [Abstract][Full Text] [Related]
9. ARPC1B is a novel prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune infiltration.
Tang YF; Qiao B; Huang YB; Wang M
Front Mol Biosci; 2023; 10():1202524. PubMed ID: 37795220
[No Abstract] [Full Text] [Related]
10. Decreased expression of HADH is related to poor prognosis and immune infiltration in kidney renal clear cell carcinoma.
Jiang H; Chen H; Wan P; Chen N
Genomics; 2021 Nov; 113(6):3556-3564. PubMed ID: 34391866
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value and immunological role of the small mother against decapentaplegic proteins in kidney renal clear cell carcinoma.
Zhang S; Liu Z; Xiao M; Liu H
Transl Cancer Res; 2021 Jun; 10(6):2678-2693. PubMed ID: 35116580
[TBL] [Abstract][Full Text] [Related]
12. miR-21-5p/PRKCE axis implicated in immune infiltration and poor prognosis of kidney renal clear cell carcinoma.
Wang J; Jin J; Liang Y; Zhang Y; Wu N; Fan M; Zeng F; Deng F
Front Genet; 2022; 13():978840. PubMed ID: 36186442
[TBL] [Abstract][Full Text] [Related]
13. CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma.
Zhou F; Shen D; Xiong Y; Cheng S; Xu H; Wang G; Qian K; Ju L; Zhang X
Front Oncol; 2020; 10():570819. PubMed ID: 33628726
[TBL] [Abstract][Full Text] [Related]
14. The combination of NDUFS1 with CD4
Wu D; He L; Xu Z; Tian RF; Fan XY; Fan J; Ai J; Bian HJ; Qin WJ; Qin J; Li L
Front Cell Dev Biol; 2023; 11():1168462. PubMed ID: 37469574
[No Abstract] [Full Text] [Related]
15. CYP2J2 Is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma.
Zou X; Mo Z
Biomed Res Int; 2021; 2021():3771866. PubMed ID: 34258261
[TBL] [Abstract][Full Text] [Related]
16. FBLN5 as One Presumably Prognostic Gene Potentially Modulating Tumor Immune Microenvironment for Renal Clear Cell Carcinoma in Children and Young Adults.
Zhang M; Chen F; Feng S; Liu X; Wang Z; Shen N; Meng L; Zhu D; Zhu Z
Pharmgenomics Pers Med; 2024; 17():27-40. PubMed ID: 38264064
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the basement membrane in kidney renal clear cell carcinoma to guide clinical therapy.
Xiong X; Chen C; Yang J; Ma L; Wang X; Zhang W; Yuan Y; Peng M; Li L; Luo P
Front Oncol; 2022; 12():1024956. PubMed ID: 36439501
[TBL] [Abstract][Full Text] [Related]
18. HOXD1 functions as a novel tumor suppressor in kidney renal clear cell carcinoma.
Cui Y; Zhang C; Li Y; Ma S; Cao W; Guan F
Cell Biol Int; 2021 Jun; 45(6):1246-1259. PubMed ID: 33559901
[TBL] [Abstract][Full Text] [Related]
19. Overexpressing IFITM family genes predict poor prognosis in kidney renal clear cell carcinoma.
Xu Y; Huang D; Zhang K; Tang Z; Ma J; Zhu M; Xiong H
Transl Androl Urol; 2021 Oct; 10(10):3837-3851. PubMed ID: 34804826
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of the expression, prognosis and biological significance of FSCN family in clear cell renal cell carcinoma.
Lin Y; Chen R; Jiang M; Hu B; Zheng P; Chen G
Oncol Lett; 2023 Sep; 26(3):379. PubMed ID: 37559574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
